Examination of potential mechanisms of amyloid-induced defects in neuronal transport

Neurobiology of Disease

Volumn 36, Issue 1, 2009, Pages 11-25

  Shah, Sameer B ^a   Nolan, Rhiannon ^b   Davis, Emily ^b   Stokin, Gorazd B ^c   Niesman, Ingrid ^b   Canto, Isabel ^d   Glabe, Charles ^d   Goldstein, Lawrence S B ^b,e  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aggregation; Alzheimer's disease; Amyloid; Axonal transport; Morphology; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; POLYSTYRENE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BRAIN NERVE CELL; CELL TRANSPORT; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; EXTRACELLULAR CALCIUM; FIBER; IMAGING SYSTEM; IMMUNOFLUORESCENCE; INTERNALIZATION; MEMBRANE PERMEABILITY; MOUSE; NERVE CELL NECROSIS; NERVE FIBER; NERVE FIBER TRANSPORT; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEREOLOGY;

AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; BIOLOGICAL TRANSPORT; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC CMP; DENDRITES; HIPPOCAMPUS; LUMINESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSPHERES; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; NEUROFILAMENT PROTEINS; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; POLYSTYRENES; REACTIVE OXYGEN SPECIES; TAU PROTEINS; TRANSFECTION;

EID: 69949102785     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.05.016     Document Type: Article

References (111)

1. Adalbert R., Gilley J., and Coleman M.P. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. Trends Mol. Med. 13 (2007) 135-142
2. Adle-Biassette H., Chretien F., Wingertsmann L., Hery C., Ereau T., Scaravilli F., Tardieu M., and Gray F. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25 (1999) 123-133
3. Anderson K.L., and Ferreira A. alpha1 Integrin activation: a link between beta-amyloid deposition and neuronal death in aging hippocampal neurons. J. Neurosci. Res. 75 (2004) 688-697
4. Behl C., and Sagara Y. Mechanism of amyloid beta protein induced neuronal cell death: current concepts and future perspectives. J. Neural Transm., Suppl. 49 (1997) 125-134
5. Behl C., Davis J.B., Klier F.G., and Schubert D. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res. 645 (1994) 253-264
6. Benzing W.C., Mufson E.J., and Armstrong D.M. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present. Brain Res. 606 (1993) 10-18
7. Best J.D., Jay M.T., Otu F., Ma J., Nadin A., Ellis S., Lewis H.D., Pattison C., Reilly M., Harrison T., Shearman M.S., Williamson T.L., and Atack J.R. Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6- ox o-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide]. J. Pharmacol. Exp. Ther. 313 (2005) 902-908
8. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
9. Burdick D., Kosmoski J., Knauer M.F., and Glabe C.G. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res. 746 (1997) 275-284
10. Calderon F.H., Bonnefont A., Munoz F.J., Fernandez V., Videla L.A., and Inestrosa N.C. PC12 and neuro 2a cells have different susceptibilities to acetylcholinesterase-amyloid complexes, amyloid25-35 fragment, glutamate, and hydrogen peroxide. J. Neurosci. Res. 56 (1999) 620-631
11. Canevari L., Abramov A.Y., and Duchen M.R. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem. Res. 29 (2004) 637-650
12. Carette B., Poulain P., and Delacourte A. Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons. Neurosci. Lett. 151 (1993) 111-114
13. Cash A.D., Aliev G., Siedlak S.L., Nunomura A., Fujioka H., Zhu X., Raina A.K., Vinters H.V., Tabaton M., Johnson A.B., Paula-Barbosa M., Avila J., Jones P.K., Castellani R.J., Smith M.A., and Perry G. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am. J. Pathol. 162 (2003) 1623-1627
14. Cheng C.L., and Povlishock J.T. The effect of traumatic brain injury on the visual system: a morphologic characterization of reactive axonal change. J. Neurotrauma 5 (1988) 47-60
15. Cherny R.A., Legg J.T., McLean C.A., Fairlie D.P., Huang X., Atwood C.S., Beyreuther K., Tanzi R.E., Masters C.L., and Bush A.I. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J. Biol. Chem. 274 (1999) 23223-23228
16. Cirrito J.R., May P.C., O'Dell M.A., Taylor J.W., Parsadanian M., Cramer J.W., Audia J.E., Nissen J.S., Bales K.R., Paul S.M., DeMattos R.B., and Holtzman D.M. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J. Neurosci. 23 (2003) 8844-8853
17. Cook D.G., Forman M.S., Sung J.C., Leight S., Kolson D.L., Iwatsubo T., Lee V.M., and Doms R.W. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3 (1997) 1021-1023
18. Counterman A.E., D'Onofrio T.G., Andrews A.M., and Weiss P.S. A physical model of axonal damage due to oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5262-5266
19. Craig A.M., Blackstone C.D., Huganir R.L., and Banker G. The distribution of glutamate receptors in cultured rat hippocampal neurons: postsynaptic clustering of AMPA-selective subunits. Neuron 10 (1993) 1055-1068
20. Dai J., Buijs R.M., Kamphorst W., and Swaab D.F. Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes. Brain Res. 948 (2002) 138-144
21. De Vries L., Elenko E., McCaffery J.M., Fischer T., Hubler L., McQuistan T., Watson N., and Farquhar M.G. RGS-GAIP, a GTPase-activating protein for Galphai heterotrimeric G proteins, is located on clathrin-coated vesicles. Mol. Biol. Cell 9 (1998) 1123-1134
22. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
23. Dixit R., and Cyr R. Cell damage and reactive oxygen species production induced by fluorescence microscopy: effect on mitosis and guidelines for non-invasive fluorescence microscopy. Plant J. 36 (2003) 280-290
24. Duyckaerts C., Potier M.C., and Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. 115 (2008) 5-38
25. Echeverria V., and Cuello A.C. Intracellular A-beta amyloid, a sign for worse things to come?. Mol. Neurobiol. 26 (2002) 299-316
26. Edgar J.M., McLaughlin M., Yool D., Zhang S.C., Fowler J.H., Montague P., Barrie J.A., McCulloch M.C., Duncan I.D., Garbern J., Nave K.A., and Griffiths I.R. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166 (2004) 121-131
27. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120 Pt 3 (1997) 393-399
28. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., Serrano J., Bentura M.L., Martinez-Murillo R., Martinez A., and Rodrigo J. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol. Histopathol. 19 (2004) 823-844
29. Ferrari A., Hoerndli F., Baechi T., Nitsch R.M., and Gotz J. beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J. Biol. Chem. 278 (2003) 40162-40168
30. Ferrer I., Guionnet N., Cruz-Sanchez F., and Tunon T. Neuronal alterations in patients with dementia: a Golgi study on biopsy samples. Neurosci. Lett. 114 (1990) 11-16
31. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., and Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 362 (1993) 543-546
32. Francesconi A., and Duvoisin R.M. Alternative splicing unmasks dendritic and axonal targeting signals in metabotropic glutamate receptor 1. J. Neurosci. 22 (2002) 2196-2205
33. Galasko D.R., Graff-Radford N., May S., Hendrix S., Cottrell B.A., Sagi S.A., Mather G., Laughlin M., Zavitz K.H., Swabb E., Golde T.E., Murphy M.P., and Koo E.H. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Dis. Assoc. Disord. 21 (2007) 292-299
34. Gallo G. Myosin II activity is required for severing-induced axon retraction in vitro. Exp. Neurol. 189 (2004) 112-121
35. Galvin J.E., Uryu K., Lee V.M., and Trojanowski J.Q. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13450-13455
36. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17 (2001) 137-145
37. Gonatas N.K., Anderson W., and Evangelista I. The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementia. J. Neuropathol. Exp. Neurol. 26 (1967) 25-39
38. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., and Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10417-10422
39. Gotz J., Ittner L.M., and Kins S. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?. J. Neurochem. 98 (2006) 993-1006
40. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., and Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156 (2000) 15-20
41. Gouras G.K., Almeida C.G., and Takahashi R.H. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26 (2005) 1235-1244
42. Greenbaum L., Rothmann C., Lavie R., and Malik Z. Green fluorescent protein photobleaching: a model for protein damage by endogenous and exogenous singlet oxygen. Biol. Chem. 381 (2000) 1251-1258
43. Griffin B.A., Adams S.R., Jones J., and Tsien R.Y. Fluorescent labeling of recombinant proteins in living cells with FlAsH. Methods Enzymol. 327 (2000) 565-578
44. Gunawardena S., and Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32 (2001) 389-401
45. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D., Roberts G.W., Masters C.L., Dotti C.G., Unsicker K., and Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat. Med. 3 (1997) 1016-1020
46. He Y., Francis F., Myers K.A., Yu W., Black M.M., and Baas P.W. Role of cytoplasmic dynein in the axonal transport of microtubules and neurofilaments. J. Cell Biol. 168 (2005) 697-703
47. Hiruma H., Katakura T., Takahashi S., Ichikawa T., and Kawakami T. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J. Neurosci. 23 (2003) 8967-8977
48. Hossain S., Grande M., Ahmadkhanov G., and Pramanik A. Binding of the Alzheimer amyloid beta-peptide to neuronal cell membranes by fluorescence correlation spectroscopy. Exp. Mol. Pathol. 82 (2007) 169-174
49. Ikonomovic M.D., Abrahamson E.E., Isanski B.A., Wuu J., Mufson E.J., and DeKosky S.T. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. Arch. Neurol. 64 (2007) 1312-1317
50. Ivins K.J., Bui E.T., and Cotman C.W. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol. Dis. 5 (1998) 365-378
51. Jimenez-Banzo A., Nonell S., Hofkens J., and Flors C. Singlet oxygen photosensitization by EGFP and its chromophore HBDI. Biophys. J. 94 (2008) 168-172
52. Kaasik A., Safiulina D., Choubey V., Kuum M., Zharkovsky A., and Veksler V. Mitochondrial swelling impairs the transport of organelles in cerebellar granule neurons. J. Biol. Chem. 282 (2007) 32821-32826
53. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 (2001) 643-648
54. Kasa P., Papp H., Kovacs I., Forgon M., Penke B., and Yamaguchi H. Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Neurosci. Lett. 278 (2000) 117-119
55. Kawahara M., and Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 53 (2000) 389-397
56. Kayed R., Head E., Sarsoza F., Saing T., Cotman C.W., Necula M., Margol L., Wu J., Breydo L., Thompson J.L., Rasool S., Gurlo T., Butler P., and Glabe C.G. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2 (2007) 18
57. Kienlen-Campard P., Miolet S., Tasiaux B., and Octave J.N. Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 277 (2002) 15666-15670
58. King M.E., Kan H.M., Baas P.W., Erisir A., Glabe C.G., and Bloom G.S. Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J. Cell Biol. 175 (2006) 541-546
59. Knauer M.F., Soreghan B., Burdick D., Kosmoski J., and Glabe C.G. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 7437-7441
60. Koh J.Y., Yang L.L., and Cotman C.W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533 (1990) 315-320
61. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., Viola K.L., and Klein W.L. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27 (2007) 796-807
62. Lazarov O., Morfini G.A., Pigino G., Gadadhar A., Chen X., Robinson J., Ho H., Brady S.T., and Sisodia S.S. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J. Neurosci. 27 (2007) 7011-7020
63. Liberski P.P., and Budka H. Neuroaxonal pathology in Creutzfeldt-Jakob disease. Acta Neuropathol. (Berl) 97 (1999) 329-334
64. Ligon L.A., and Steward O. Movement of mitochondria in the axons and dendrites of cultured hippocampal neurons. J. Comp. Neurol. 427 (2000) 340-350
65. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., and Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7951-7955
66. Lorenzo A., and Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12243-12247
67. Maloney M.T., Minamide L.S., Kinley A.W., Boyle J.A., and Bamburg J.R. Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J. Neurosci. 25 (2005) 11313-11321
68. Masliah E., Mallory M., Deerinck T., DeTeresa R., Lamont S., Miller A., Terry R.D., Carragher B., and Ellisman M. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 52 (1993) 619-632
69. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., and Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16 (1996) 5795-5811
70. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
71. Morris R.L., and Hollenbeck P.J. Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J. Cell Biol. 131 (1995) 1315-1326
72. Naarala J., Nykvist P., Tuomala M., and Savolainen K. Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett. 330 (1993) 222-226
73. Perry G., Roder H., Nunomura A., Takeda A., Friedlich A.L., Zhu X., Raina A.K., Holbrook N., Siedlak S.L., Harris P.L., and Smith M.A. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. NeuroReport 10 (1999) 2411-2415
74. Phinney A.L., Horne P., Yang J., Janus C., Bergeron C., and Westaway D. Mouse models of Alzheimer's disease: the long and filamentous road. Neurol. Res. 25 (2003) 590-600
75. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 (1993) 1676-1687
76. Praprotnik D., Smith M.A., Richey P.L., Vinters H.V., and Perry G. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress. Acta Neuropathol. (Berl) 91 (1996) 1-5
77. Price J.L., and Morris J.C. So what if tangles precede plaques?. Neurobiol. Aging 25 (2004) 721-723 discussion 743-726
78. Probst A., Basler V., Bron B., and Ulrich J. Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res. 268 (1983) 249-254
79. Rudrabhatla P., Zheng Y.L., Amin N.D., Kesavapany S., Albers W., and Pant H.C. Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein. J. Biol. Chem. 283 (2008) 26737-26747
80. Savage M.J., Trusko S.P., Howland D.S., Pinsker L.R., Mistretta S., Reaume A.G., Greenberg B.D., Siman R., and Scott R.W. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18 (1998) 1743-1752
81. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 3 (2001) 75-80
82. Shaked G.M., Kummer M.P., Lu D.C., Galvan V., Bredesen D.E., and Koo E.H. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J. 20 (2006) 1254-1256
83. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., and Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14 (2008) 837-842
84. Skovronsky D.M., Doms R.W., and Lee V.M. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell Biol. 141 (1998) 1031-1039
85. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., Sayre L.M., and Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64 (1995) 2660-2666
86. Smith M.A., Siedlak S.L., Richey P.L., Nagaraj R.H., Elhammer A., and Perry G. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease. Brain Res. 717 (1996) 99-108
87. Smith D.H., Chen X.H., Nonaka M., Trojanowski J.Q., Lee V.M., Saatman K.E., Leoni M.J., Xu B.N., Wolf J.A., and Meaney D.F. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J. Neuropathol. Exp. Neurol. 58 (1999) 982-992
88. Smith D.H., Uryu K., Saatman K.E., Trojanowski J.Q., and McIntosh T.K. Protein accumulation in traumatic brain injury. Neuromol. Med. 4 (2003) 59-72
89. Song M.S., Saavedra L., and de Chaves E.I. Apoptosis is secondary to non-apoptotic axonal degeneration in neurons exposed to Abeta in distal axons. Neurobiol. Aging 27 (2006) 1224-1238
90. Spires T.L., and Hyman B.T. Neuronal structure is altered by amyloid plaques. Rev. Neurosci. 15 (2004) 267-278
91. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., and Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 (2005) 1282-1288
92. Su J.H., Cummings B.J., and Cotman C.W. Identification and distribution of axonal dystrophic neurites in Alzheimer's disease. Brain Res. 625 (1993) 228-237
93. Takahashi R.H., Nam E.E., Edgar M., and Gouras G.K. Alzheimer beta-amyloid peptides: normal and abnormal localization. Histol. Histopathol. 17 (2002) 239-246
94. Takahashi R.H., Almeida C.G., Kearney P.F., Yu F., Lin M.T., Milner T.A., and Gouras G.K. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24 (2004) 3592-3599
95. Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R., and Suzumura A. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 280 (2005) 10444-10454
96. Takuma H., Tomiyama T., Kuida K., and Mori H. Amyloid beta peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo. J. Neuropathol. Exp. Neurol. 63 (2004) 255-261
97. Tan S., Wood M., and Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71 (1998) 95-105
98. Taylor B.M., Sarver R.W., Fici G., Poorman R.A., Lutzke B.S., Molinari A., Kawabe T., Kappenman K., Buhl A.E., and Epps D.E. Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40: a kinetic model. J. Protein. Chem. 22 (2003) 31-40
99. Tour O., Meijer R.M., Zacharias D.A., Adams S.R., and Tsien R.Y. Genetically targeted chromophore-assisted light inactivation. Nat. Biotechnol. 21 (2003) 1505-1508
100. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7 (2004) 1181-1183
101. Verdier Y., Zarandi M., and Penke B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 10 (2004) 229-248
102. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
103. Wataya T., Nunomura A., Smith M.A., Siedlak S.L., Harris P.L., Shimohama S., Szweda L.I., Kaminski M.A., Avila J., Price D.L., Cleveland D.W., Sayre L.M., and Perry G. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277 (2002) 4644-4648
104. Whalen B.M., Selkoe D.J., and Hartley D.M. Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration. Neurobiol. Dis. 20 (2005) 254-266
105. Yang A.J., Chandswangbhuvana D., Shu T., Henschen A., and Glabe C.G. Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42. J. Biol. Chem. 274 (1999) 20650-20656
106. Yankner B.A., Caceres A., and Duffy L.K. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9020-9023
107. Yankner B.A., Duffy L.K., and Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250 (1990) 279-282
108. Yoshiike Y., Akagi T., and Takashima A. Surface structure of amyloid-beta fibrils contributes to cytotoxicity. Biochemistry 46 (2007) 9805-9812
109. Zhang Z., Rydel R.E., Drzewiecki G.J., Fuson K., Wright S., Wogulis M., Audia J.E., May P.C., and Hyslop P.A. Amyloid beta-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation. J. Neurochem. 67 (1996) 1595-1606
110. Zheng G., Chen J., Stefflova K., Jarvi M., Li H., and Wilson B.C. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8989-8994
111. Zou K., Kim D., Kakio A., Byun K., Gong J.S., Kim J., Kim M., Sawamura N., Nishimoto S., Matsuzaki K., Lee B., Yanagisawa K., and Michikawa M. Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain. J. Neurochem. 87 (2003) 609-619